Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Obesity and methotrexate treatment failure in rheumatoid arthritis patients in Cipto Mangunkusumo Hospital, Indonesia

International Journal of Public Health Science · Vol. 13 No. 3 (2024) · hlm. 1071–1078

DOI
10.11591/ijphs.v13i3.24046
ISSN
2620-4126, 2252-8806
Terbit
2024-09-01
Penerbit
Intelektual Pustaka Media Utama
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease which mainly manifests in the joints. Methotrexate (MTX) is a widely used pharmacological treatment for RA. To date, no prior research has investigated the effect of obesity on MTX treatment outcomes among RA patients in Indonesia. This research aimed to investigate the effect of obesity on MTX monotherapy failure in RA patients. We conducted a retrospective cohort study using medical records from the Rheumatology Clinic at Cipto Mangunkusumo Hospital from March 2017 to December 2021. Descriptive and estimation analyses were performed to assess the sample characteristics based on each variable and a logistic regression analysis was conducted to evaluate the association between obesity and MTX treatment failure. Out of 72 subjects, the proportion of MTX treatment failure was 57.1% (20/35) among obese patients and 37.8% (14/37) among non-obese patients. Obese subjects exhibited a 2.11-fold increased risk of MTX treatment failure compared to non-obese patients (OR 2.11; 95% CI 0.81-5.45). The number of joints involved was found to emerge as a confounding factor in this study. Our findings suggest that RA patients with obesity potentially have an increased risk of MTX treatment failure compared to non-obese RA patients.

Jaringan kolaborasi para penulis

29 penulis · 71 tautan kepenulisan bersama · 33 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Sriwijaya University
  • Padjadjaran University
  • Joint United Nations Programme on HIV/AIDS
  • Kementerian Kesehatan Republik Indonesia
  • Hasanuddin University
  • Universitas Prima Nusantara Bukittinggi
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Lely WahyuniarJoint United Nations Programme on HIV/AIDS1
Bambang SutrisnaUniversity of Indonesia1
Abas B. DjauhariKementerian Kesehatan Republik Indonesia1
Jumriani AnsarHasanuddin University1
Sudarto RonoatmodjoUniversity of Indonesia1
Farid HusinPadjadjaran University1
Muliani RatnaningsihPadjadjaran University1
Evi MarthaUniversity of Indonesia1
Besral BesralUniversity of Indonesia1
Cici Apriza YantiUniversitas Prima Nusantara Bukittinggi1
Siti NurmainiSriwijaya University1
Hadi SyaputraSriwijaya University1
Muhammad Taufik RosenoSriwijaya University1
Tri Yunis Miko WahyonoUniversity of Indonesia1
Kholisotul HikmahUniversity of Indonesia1
Ikrimah NafilataSekolah Tinggi Ilmu Kesehatan Yogyakarta1
Taniawati SupaliUniversity of Indonesia1
Yuli Puspita DeviUniversitas Airlangga1
Utami PurbasariFatmawati Hospital1
Helda HeldaUniversity of Indonesia1
Budhi AntariksaAfiliasi tidak diketahui1
Fatira Ratri AuditaUniversity of Indonesia1
Fidya RumiatiAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://ijphs.iaescore.com/index.php/IJPHS/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Obesity and methotrexate treatment failure in rheumatoid arthritis patients in Cipto Mangunkusumo Hospital, Indonesia</dc:title>
	<dc:creator>Fauzia, Fara</dc:creator>
	<dc:creator>Adnan Prihartono, Nurhayati</dc:creator>
	<dc:creator>C. Adisasmita, Asri</dc:creator>
	<dc:creator>Umi Partan, Radiyati</dc:creator>
	<dc:creator>Djuwita Hatma, Ratna</dc:creator>
	<dc:creator>Hidayat, Rudy</dc:creator>
	<dc:description xml:lang="en-US">Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease which mainly manifests in the joints. Methotrexate (MTX) is a widely used pharmacological treatment for RA. To date, no prior research has investigated the effect of obesity on MTX treatment outcomes among RA patients in Indonesia. This research aimed to investigate the effect of obesity on MTX monotherapy failure in RA patients. We conducted a retrospective cohort study using medical records from the Rheumatology Clinic at Cipto Mangunkusumo Hospital from March 2017 to December 2021. Descriptive and estimation analyses were performed to assess the sample characteristics based on each variable and a logistic regression analysis was conducted to evaluate the association between obesity and MTX treatment failure. Out of 72 subjects, the proportion of MTX treatment failure was 57.1% (20/35) among obese patients and 37.8% (14/37) among non-obese patients. Obese subjects exhibited a 2.11-fold increased risk of MTX treatment failure compared to non-obese patients (OR 2.11; 95% CI 0.81-5.45). The number of joints involved was found to emerge as a confounding factor in this study. Our findings suggest that RA patients with obesity potentially have an increased risk of MTX treatment failure compared to non-obese RA patients.</dc:description>
	<dc:publisher xml:lang="en-US">Intelektual Pustaka Media Utama</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2024-09-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijphs.iaescore.com/index.php/IJPHS/article/view/24046</dc:identifier>
	<dc:identifier>10.11591/ijphs.v13i3.24046</dc:identifier>
	<dc:source xml:lang="en-US">International Journal of Public Health Science (IJPHS); Vol 13, No 3: September 2024; 1071-1078</dc:source>
	<dc:source>2620-4126</dc:source>
	<dc:source>2252-8806</dc:source>
	<dc:source>10.11591/ijphs.v13i3</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijphs.iaescore.com/index.php/IJPHS/article/view/24046/14084</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Institute of Advanced Engineering and Science</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>